Indivior Pharmaceuticals (INDV) Cash & Equivalents Growth (3y) (2024 - 2025)

Indivior Pharmaceuticals (INDV) Cash & Equivalents Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 29.96%
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 20.41%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -2.73%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -2.02%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 3.22%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 52.71%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 36.93%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 10.41%
10 Indivior Pharmaceuticals 5.00 Bn 4.82 Bn 277.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -36.84%
Dec 31, 2024 -33.85%